These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34157655)

  • 21. Mammographic density-a review on the current understanding of its association with breast cancer.
    Huo CW; Chew GL; Britt KL; Ingman WV; Henderson MA; Hopper JL; Thompson EW
    Breast Cancer Res Treat; 2014 Apr; 144(3):479-502. PubMed ID: 24615497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
    Masarwah A; Auvinen P; Sudah M; Dabravolskaite V; Arponen O; Sutela A; Oikari S; Kosma VM; Vanninen R
    BMC Cancer; 2016 Nov; 16(1):833. PubMed ID: 27806715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer.
    Li Y; Cao J; Zhou Y; Mao F; Shen S; Sun Q
    Sci Rep; 2019 Jul; 9(1):10544. PubMed ID: 31332233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting mammographic density with linear ultrasound transducers.
    Behrens A; Fasching PA; Schwenke E; Gass P; Häberle L; Heindl F; Heusinger K; Lotz L; Lubrich H; Preuß C; Schneider MO; Schulz-Wendtland R; Stumpfe FM; Uder M; Wunderle M; Zahn AL; Hack CC; Beckmann MW; Emons J
    Eur J Med Res; 2023 Sep; 28(1):384. PubMed ID: 37770952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammographic Density Reduction is Associated to the Prognosis in Asian Breast Cancer Patients Receiving Hormone Therapy.
    Shia WC; Lin LS; Wu HK; Chen CJ; Chen DR
    Cancer Control; 2023; 30():10732748231160991. PubMed ID: 36866691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Diao P; Nielsen MB; Uldall WY; Vejborg I
    BMC Cancer; 2015 Apr; 15():274. PubMed ID: 25884160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body size in early life and risk of breast cancer.
    Shawon MSR; Eriksson M; Li J
    Breast Cancer Res; 2017 Jul; 19(1):84. PubMed ID: 28732505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Interactions Between Mammographic Density Phenotypes and Established Risk Factors With Breast Cancer Risk, by Tumor Subtype and Menopausal Status.
    Chen H; Yaghjyan L; Li C; Peters U; Rosner B; Lindström S; Tamimi RM
    Am J Epidemiol; 2021 Jan; 190(1):44-58. PubMed ID: 32639533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
    Miglietta F; Dieci MV; Tsvetkova V; Griguolo G; Vernaci G; Menichetti A; Faggioni G; Giarratano T; Mioranza E; Genovesi E; Cumerlato E; Bottosso M; Saibene T; Michieletto S; Lo Mele M; Conte P; Guarneri V
    Oncologist; 2020 Sep; 25(9):e1355-e1362. PubMed ID: 32618068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p-mTOR expression is associated with better prognosis in luminal breast carcinoma.
    Beca F; Andre R; Martins DS; Bilhim T; Martins D; Schmitt F
    J Clin Pathol; 2014 Nov; 67(11):961-7. PubMed ID: 25053543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of internal mammary lymph nodes (IMLN) metastasis and disease-free survival comparison between IMLN-positive and IMLN-negative breast cancer patients: Results from Western China Clinical Cooperation Group (WCCCG) database (CONSORT).
    Wang K; Zhang X; Zheng K; Yin XD; Xing L; Zhang AJ; Shi Y; Kong LQ; Li F; Ma BL; Li H; Liu JP; Jiang J; Ren GS; Li HY
    Medicine (Baltimore); 2018 Jul; 97(28):e11296. PubMed ID: 29995764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is mammographic density a marker of breast cancer phenotypes?
    Kanbayti IH; Rae WID; McEntee MF; Al-Foheidi M; Ashour S; Turson SA; Ekpo EU
    Cancer Causes Control; 2020 Aug; 31(8):749-765. PubMed ID: 32410205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.
    Zeichner SB; Cavalcante L; Suciu GP; Ruiz AL; Hirzel A; Krill-Jackson E
    Asian Pac J Cancer Prev; 2014; 15(8):3435-41. PubMed ID: 24870735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammographic density and breast cancer in women from high risk families.
    Ramón Y Cajal T; Chirivella I; Miranda J; Teule A; Izquierdo Á; Balmaña J; Sánchez-Heras AB; Llort G; Fisas D; Lope V; Hernández-Agudo E; Juan-Fita MJ; Tena I; Robles L; Guillén-Ponce C; Pérez-Segura P; Luque-Molina MS; Hernando-Polo S; Salinas M; Brunet J; Salas-Trejo MD; Barnadas A; Pollán M
    Breast Cancer Res; 2015 Jul; 17(1):93. PubMed ID: 26163143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 39. The Relationship Between Mammographic Density and Factors Affecting Breast Cancer Risk.
    Kocer HB; Menekse E; Turan U; Namdaroglu O; Barca AN; Araz L; Ozdemir BA; Bozkurt B
    Sisli Etfal Hastan Tip Bul; 2022; 56(1):119-125. PubMed ID: 35515977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
    Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.